Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue BMC Cancer Année : 2011

Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review

Résumé

Chordomas are very rare low-grade malignant bone tumors that arise from the embryonic rests of the notochord. They are characterized by slow growth and long history with frequent local relapses, and sometimes metastases. While chemotherapy is not efficient, imatinib has shown antitumor activity. Case presentation We report on a 76-year-old patient with EGFR-overexpressing advanced chordoma that progressed on imatinib and subsequently responded to erlotinib during 12 months. Conclusions We report the fourth case of advanced chordoma treated with an EGFR inhibitor. We also review the literature concerning the rationale and potential of EGFR targeting in chordoma.

Domaines

Cancer
Fichier principal
Vignette du fichier
1471-2407-11-423.pdf (1.55 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : CC BY - Paternité

Dates et versions

hal-03623791 , version 1 (24-10-2023)

Licence

Paternité

Identifiants

Citer

Simon Launay, Bruno Chetaille, Fanny Medina, Delphine Perrot, Serge Nazarian, et al.. Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review. BMC Cancer, 2011, 11 (1), pp.423. ⟨10.1186/1471-2407-11-423⟩. ⟨hal-03623791⟩

Collections

INSERM UNIV-AMU
11 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More